EUVIMEDEUVIMED entdecken
Crossref

Effects of phototherapy plus agomelatine on efficacy, negative emotions, and neurotransmitter levels in elderly patients with depressive disorders

Ping-Jing Jiang, Shu-Wei Hu, Chun-Mei Liao, Jing-Jing Peng, Sheng-Jian Liang, Xue Cheng

World Journal of Psychiatry · 19.07.2026 · 16 (7)

DOI: 10.5498/wjp.117216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Psychiatry, online erschienen am 19.07.2026. Verfasst von Ping-Jing Jiang und 5 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Treatment outcomes in patients with depressive disorders remain suboptimal, necessitating exploration of improved therapeutic strategies. AIM To evaluate the effects of phototherapy plus agomelatine on treatment efficacy, negative emotions, and neurotransmitter levels in elderly patients with depressive disorders. METHODS From August 2024 to May 2025, 127 elderly patients with depressive disorder admitted to Chongqing Mental Health Center were enrolled and assigned to control (n = 60, agomelatine monotherapy) and research (n = 67, phototherapy plus agomelatine) groups. The two groups were compared regarding overall efficacy; Hamilton Anxiety Scale scores, Hamilton Depression Scale (HAMD) scores, and Pittsburgh Sleep Quality Index scores; levels of dopamine (DA), norepinephrine, serotonin, superoxide dismutase, and malondialdehyde; and safety outcomes (nausea and vomiting, dry mouth, sweating, headache, and eye fatigue). The number needed to treat was calculated to assess the correlation between neurotransmitter changes and clinical improvement. RESULTS Compared with the control group (needed to treat: 8), the research group demonstrated a significantly higher total effective rate, lower post-treatment Hamilton Anxiety Scale, HAMD, and Pittsburgh Sleep Quality Index scores, and malondialdehyde levels, and higher post-treatment DA, norepinephrine, serotonin, and superoxide dismutase levels. ΔDA showed a significant positive correlation with the reduction rate of HAMD scores. The overall incidence of adverse events was comparable between groups. CONCLUSION Phototherapy plus agomelatine demonstrates definite therapeutic efficacy in elderly patients with depressive disorders, effectively alleviating negative emotions and improving neurotransmitter parameters.

Zitieren

APA

Jiang, P., Hu, S., Liao, C., Peng, J., Liang, S., & Cheng, X. (2026). Effects of phototherapy plus agomelatine on efficacy, negative emotions, and neurotransmitter levels in elderly patients with depressive disorders. World Journal of Psychiatry, 16(7). https://doi.org/10.5498/wjp.117216

Vancouver

Jiang P, Hu S, Liao C, Peng J, Liang S, Cheng X. Effects of phototherapy plus agomelatine on efficacy, negative emotions, and neurotransmitter levels in elderly patients with depressive disorders. World Journal of Psychiatry. 2026;16(7). doi:10.5498/wjp.117216

BibTeX
@article{Jiang2026,
  author = {Jiang, Ping-Jing and Hu, Shu-Wei and Liao, Chun-Mei and Peng, Jing-Jing and Liang, Sheng-Jian and Cheng, Xue},
  title = {Effects of phototherapy plus agomelatine on efficacy, negative emotions, and neurotransmitter levels in elderly patients with depressive disorders},
  journal = {World Journal of Psychiatry},
  year = {2026},
  volume = {16},
  number = {7},
  doi = {10.5498/wjp.117216}
}
Kostenlos starten →